Saxony Capital Management, LLC Adc Therapeutics Sa Transaction History
Saxony Capital Management, LLC
- $109 Billion
- Q3 2024
A detailed history of Saxony Capital Management, LLC transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Saxony Capital Management, LLC holds 22,238 shares of ADCT stock, worth $71,161. This represents 0.06% of its overall portfolio holdings.
Number of Shares
22,238
Previous 22,238
-0.0%
Holding current value
$71,161
Previous $70.3 Million
0.32%
% of portfolio
0.06%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding ADCT
# of Institutions
79Shares Held
52.8MCall Options Held
300KPut Options Held
59.3K-
Redmile Group, LLC San Francisco, CA15.3MShares$48.9 Million3.15% of portfolio
-
Prosight Management, LP Dallas, TX9.57MShares$30.6 Million9.45% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.32MShares$13.8 Million0.33% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$11.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.97MShares$9.49 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $248M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...